The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab

BACKGROUND: Emerging evidence indicates that some hematological markers have critical value in evaluating treatment response. This study was performed to determine the clinical value of hemoglobin (Hb), platelet (Plt), neutrophil‐to‐lymphocyte ratio (NLR), and platelet‐to‐lymphocyte ratio (PLR) in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Li, Xiao, Dong‐Mei, Qin, Wen, Xie, Bin‐Hua, Wang, Ting‐Hui, Huang, Hua, Zhao, Bao‐Jing, Han, Xi, Sun, Qing‐Qing, Wu, Xiu‐Di, Cen, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595377/
https://www.ncbi.nlm.nih.gov/pubmed/30779461
http://dx.doi.org/10.1002/jcla.22862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595377/
https://www.ncbi.nlm.nih.gov/pubmed/30779461
http://dx.doi.org/10.1002/jcla.22862

Ejemplares similares